StockData
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. (ATNM) stock

ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3081% below fair value
$1.35−0.14 (-9.40%)

Close on Nov 17, 2026Market cap $42.45MP/E 3.8Yield –

Actinium Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Actinium Pharmaceuticals's total debt was $900.00K at Dec 31, 2019. For fiscal 2019 it was $900.00K.

Annual total debt

PeriodPeriod endValueChange
FY2019Dec 31, 2019$900.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019$900.00K–
Q3 FY2019Sep 30, 2019$100.00K–
Q2 FY2019Jun 30, 2019$300.00K–
Q1 FY2019Mar 31, 2019$200.00K–

More Actinium Pharmaceuticals figures

See a number that looks wrong?